Elastisys are nominated ‘University spin-off of the Year’!
Posted:
“Elastisys has undergone an impressive growth journey in terms of both sales and staff. Team development has been strong from both a diversity and competence perspective.“ -The Umeå gala 2022.
Antimicrobial resistance could claim almost two million lives a year by 2050. Now, researchers believe they could use #AI to predict which bugs will become resistant so that we can better prepare.
Read the full article here.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…